People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Entasis Therapeutics Holdings Inc. | — | Biotechnology | Series B | $25.0M | $928.5M | 2020 |
David Hastings at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Hastings on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Heather Preston | 1 | 6 |
| John Mueller | 1 | 2 |
| Howard Mayer | 1 | 2 |
| David Altarac | 1 | 1 |
| David Meek | 1 | 1 |
| Elizabeth Keiley | 1 | 1 |
| Ruben Tommasi | 1 | 1 |
| Manoussos Perros | 1 | 1 |
| Michael Gutch | 1 | 1 |
| Heather Behanna | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.